Hypothesis

Core idea: In aging skeletal muscle, diminished calcineurin/NFAT signaling drives NFATc4 out of the nucleus, converting its constitutive repressive function into a permissive state for atrophy‑related gene expression and fast‑fiber reprogramming.

Mechanistic rationale: NFATc4 is constitutively nuclear in young muscle, where it recruits histone deacetylases (HDACs) to suppress the promoters of atrogenes (atrogin-1, MuRF1) and fast‑contractile genes, thereby maintaining a baseline proteostatic and fiber‑type equilibrium. Age‑associated Ca²⁺ leak through ryanodine receptors reduces sustained calcineurin activity, shifting the phosphorylation equilibrium of NFATc4 toward the cytoplasmic, inactive form. Loss of nuclear NFATc4 frees HDAC‑mediated repression, allowing FOXO‑driven transcription of atrogenes and MEF2‑dependent fast‑gene programs, which together promote proteolysis and a shift toward fast‑twitch phenotypes that are more vulnerable to atrophy.

Testable predictions:

1. In muscles from aged (24‑month) mice, immunofluorescence and subcellular fractionation will show a significant reduction in NFATc4 nuclear‑to‑cytoplasmic ratio compared with young (3‑month) controls.
2. This cytoplasmic shift will correlate with decreased calcineurin activity (measured by phosphatase assay) and increased NFATc4 phosphorylation (phospho‑specific immunoblot).
3. Concurrently, nuclear levels of HDAC1/2 at the atrogin-1 and MuRF1 promoters will drop, while FOXO1 and MEF2 occupancy rise, leading to elevated mRNA and protein of atrophy markers.
4. Pharmacological stabilization of RyR1 (e.g., with dantrolene or S107) or genetic expression of a constitutively active calcineurin subunit (AAV‑CnA*) in aged mice will restore NFATc4 nuclear localization, repress atrogene expression, and attenuate sarcopenic phenotypes (greater muscle cross‑sectional area, improved grip strength).
5. Conversely, forced cytoplasmic retention of NFATc4 in young muscle (via NFATc4‑ΔNLS mutation) will precipitate premature atrophy and fast‑fiber gene induction, mimicking the aged phenotype.

Experimental approach: Use tibialis anterior and soleus from young and aged C57BL/6 mice. Perform subcellular fractionation, western blot for total and phospho‑NFATc4, calcineurin activity assay, ChIP‑qPCR for HDAC1/2, FOXO1, MEF2 at target promoters, RNA‑seq for atrophy and fiber‑type signatures, and functional assays (grip strength, treadmill endurance). Intervention groups receive RyR1 stabilizer or AAV‑CnA* for 4 weeks prior to analysis.

Falsifiability: If aged muscle shows no change in NFATc4 localization despite reduced calcineurin activity, or if restoring nuclear NFATc4 fails to improve atrophy markers, the hypothesis would be refuted, indicating that NFATc4’s nuclear presence is not a pivotal node in sarcopenia.

References: The activity‑dependent nuclear translocation of NFATc1 during low‑frequency stimulation supports isoform‑specific regulation 1; NFATc4’s constitutive nuclear accumulation and inhibitor resistance suggest a basal regulatory role 2; attenuated calcineurin/NFAT signaling in dexamethasone atrophy links to miR‑23a downregulation and atrogene induction 3; NFAT‑mediated repression of fast contractile genes illustrates bidirectional control 4; Calsarcin‑2 modulation demonstrates pathway manipulability in adult muscle 5.